company background image
BNR

Burning Rock Biotech NasdaqGM:BNR Stock Report

Last Price

US$2.54

Market Cap

US$267.2m

7D

10.9%

1Y

-79.3%

Updated

04 Dec, 2022

Data

Company Financials +
BNR fundamental analysis
Snowflake Score
Valuation3/6
Future Growth2/6
Past Performance0/6
Financial Health6/6
Dividends0/6

BNR Stock Overview

Burning Rock Biotech Limited primarily develops and provides cancer therapy selection tests in the People's Republic of China.

Burning Rock Biotech Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Burning Rock Biotech
Historical stock prices
Current Share PriceUS$2.54
52 Week HighUS$14.00
52 Week LowUS$1.70
Beta-0.11
1 Month Change20.95%
3 Month Change-18.33%
1 Year Change-79.28%
3 Year Changen/a
5 Year Changen/a
Change since IPO-89.69%

Recent News & Updates

Recent updates

Is Burning Rock Biotech (NASDAQ:BNR) In A Good Position To Invest In Growth?

Sep 20
Is Burning Rock Biotech (NASDAQ:BNR) In A Good Position To Invest In Growth?

We're Hopeful That Burning Rock Biotech (NASDAQ:BNR) Will Use Its Cash Wisely

Mar 24
We're Hopeful That Burning Rock Biotech (NASDAQ:BNR) Will Use Its Cash Wisely

Is Burning Rock Biotech (NASDAQ:BNR) Using Debt In A Risky Way?

Aug 27
Is Burning Rock Biotech (NASDAQ:BNR) Using Debt In A Risky Way?

A Look At The Intrinsic Value Of Burning Rock Biotech Limited (NASDAQ:BNR)

Jul 23
A Look At The Intrinsic Value Of Burning Rock Biotech Limited (NASDAQ:BNR)

Is Burning Rock Biotech (NASDAQ:BNR) Using Debt Sensibly?

May 13
Is Burning Rock Biotech (NASDAQ:BNR) Using Debt Sensibly?

Shareholder Returns

BNRUS BiotechsUS Market
7D10.9%4.2%1.5%
1Y-79.3%-7.4%-14.9%

Return vs Industry: BNR underperformed the US Biotechs industry which returned -7.4% over the past year.

Return vs Market: BNR underperformed the US Market which returned -14.9% over the past year.

Price Volatility

Is BNR's price volatile compared to industry and market?
BNR volatility
BNR Average Weekly Movement12.4%
Biotechs Industry Average Movement11.1%
Market Average Movement7.4%
10% most volatile stocks in US Market15.6%
10% least volatile stocks in US Market3.3%

Stable Share Price: BNR is more volatile than 75% of US stocks over the past 3 months, typically moving +/- 12% a week.

Volatility Over Time: BNR's weekly volatility (12%) has been stable over the past year, but is still higher than 75% of US stocks.

About the Company

FoundedEmployeesCEOWebsite
20141,394Yusheng Hanhttps://www.brbiotech.com

Burning Rock Biotech Limited primarily develops and provides cancer therapy selection tests in the People's Republic of China. It operates in three segments: Central Laboratory Business, In-Hospital Business, and Pharma Research and Development Services. The company primarily offers next-generation sequencing-based cancer therapy selection and prognosis prediction tests applicable to a range of cancer types, including lung cancer, gastrointestinal cancer, prostate cancer, breast cancer, lymphomas, thyroid cancer, colorectal cancer, ovarian cancer, pancreatic cancer, and bladder cancer using tissue and liquid biopsy samples.

Burning Rock Biotech Limited Fundamentals Summary

How do Burning Rock Biotech's earnings and revenue compare to its market cap?
BNR fundamental statistics
Market CapUS$267.18m
Earnings (TTM)-US$143.34m
Revenue (TTM)US$80.97m

3.3x

P/S Ratio

-1.9x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
BNR income statement (TTM)
RevenueCN¥568.35m
Cost of RevenueCN¥184.19m
Gross ProfitCN¥384.16m
Other ExpensesCN¥1.39b
Earnings-CN¥1.01b

Last Reported Earnings

Sep 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)-9.57
Gross Margin67.59%
Net Profit Margin-177.03%
Debt/Equity Ratio0%

How did BNR perform over the long term?

See historical performance and comparison